Literature DB >> 14756430

Large segment allograft survival is improved with intramedullary cement.

Craig H Gerrand1, Anthony M Griffin, Aileen M Davis, Allan E Gross, Robert S Bell, Jay S Wunder.   

Abstract

BACKGROUND AND OBJECTIVES: The most common cause of failure in large segment bone allografts used for oncologic reconstruction is allograft fracture. Reinforcement with pressurized intramedullary cement may improve the mechanical properties of allografts.
METHODS: We reviewed the prospectively collected records of 45 patients who underwent en bloc resection of an extremity bone tumor and reconstruction using an allograft with intramedullary cement.
RESULTS: Seven allografts were used for arthrodesis, 20 were intercalary, and 18 were osteochondral. Twenty eight of 45 patients were alive at a mean 5.8 years (SD 1.9; range 3-11.2) with 24 allografts in situ. In these 45 patients, there were four allograft fractures and four infections. Six of these complications resulted in allograft removal. The estimated 5-year allograft survival rate was 86% (95% confidence interval 74-98%). Seven patients required secondary autogenous bone grafting for non-unions. Function measured by the Toronto Extremity Salvage Score and the 1987 and 1993 Musculoskeletal Tumor Society Rating Scales demonstrated a consistent pattern with worse function in patients with osteochondral allografts and best function with intercalary allografts.
CONCLUSIONS: These results suggest the addition of intramedullary cement to large segment bone allografts improves their survival by decreasing the fracture risk, particularly for allografts used for arthrodesis and intercalary reconstructions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14756430     DOI: 10.1002/jso.10316

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Limb salvage in the skeletally immature patient.

Authors:  Valerae O Lewis
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.075

2.  Locking buttons increase fatigue life of locking plates in a segmental bone defect model.

Authors:  Marc Tompkins; David J Paller; Douglas C Moore; Joseph J Crisco; Richard M Terek
Journal:  Clin Orthop Relat Res       Date:  2012-10-27       Impact factor: 4.176

3.  The clinical outcomes of extracorporeal irradiated and re-implanted cemented autologous bone graft of femoral diaphysis after tumour resection.

Authors:  Tomoki Nakamura; Adesegun Abudu; Roger J Grimer; Simon R Carter; Lee Jeys; Roger M Tillman
Journal:  Int Orthop       Date:  2012-12-28       Impact factor: 3.075

4.  3D Customized Biological Tibial Intramedullary Nail Fixation for the Treatment of Fracture after Massive Allograft Bone Transplantation of Tibial Osteosarcoma: A Case Report.

Authors:  Hongsheng Yang; Xiang Fang; Yan Xiong; Hong Duan; Wenli Zhang
Journal:  Orthop Surg       Date:  2022-04-28       Impact factor: 2.279

5.  Survival of massive allografts in segmental oncological bone defect reconstructions.

Authors:  P H J Bullens; N M Minderhoud; M C de Waal Malefijt; R P H Veth; P Buma; H W B Schreuder
Journal:  Int Orthop       Date:  2008-12-03       Impact factor: 3.075

6.  Extracorporeal irradiated tumor bone: A reconstruction option in diaphyseal Ewing's sarcomas.

Authors:  Ajay Puri; Ashish Gulia; Mg Agarwal; Na Jambhekar; S Laskar
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

7.  Concave-convex Reaming of Intercalary Allograft: 1-year Clinical Outcomes.

Authors:  Nathan Bastien; Sean Kelly; Dustin Lybeck
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-04-20

8.  New 3-dimensional implant application as an alternative to allograft in limb salvage surgery: a technical note on 10 cases.

Authors:  Jong Woong Park; Hyun Guy Kang
Journal:  Acta Orthop       Date:  2020-07-03       Impact factor: 3.717

9.  Intercalary reconstructions with vascularised fibula and allograft after tumour resection in the lower limb.

Authors:  Katharina Rabitsch; Werner Maurer-Ertl; Ulrike Pirker-Frühauf; Christine Wibmer; Andreas Leithner
Journal:  Sarcoma       Date:  2013-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.